Therapeutic Antibody IND-enabling CMC Strategies for Bispecific Antibodies | ProBio CDMO 12-06-2022 / Rubin Jiang & Ian Chan IND-enabling CMC Strategies for Bispecific Antibodies Learn More
Therapeutic Antibody Take the Accelerated Path Upstream with IND Compliant CHOK1-GenS Cell Line Development | ProBio CDMO 06-28-2022 / Ying Li, Director of Downstream Process Development, ProBio Learn More
Therapeutic Antibody Development of cell-based functional assay with high efficiency | ProBio CDMO 02-04-2021 / Lihao Wang, Senior Scientist of In Vitro Bioassay, ProBio Learn More
Therapeutic Antibody Practical issues and strategies of biological product technology transfer | ProBio CDMO 02-04-2021 / Aipeng Deng, Senior Scientist of MAST, ProBio Learn More
Therapeutic Antibody Robust Stable Cell Line Platform for Biologics Development | ProBio CDMO 02-04-2021 / Hongxing Shi, Associate Director of Process Development, ProBio Learn More
Therapeutic Antibody Anti-idiotype Antibody Generation and Application in Antibody Drug Discovery | ProBio CDMO 01-07-2021 / Alex Chen Are you developing antibody drugs? Have you considered generating anti-idiotype antibodies (anti-IDs)? Anti-IDs recognize the region unique to your antibody drug, the complementarity determining region (CDR) Learn More
Therapeutic Antibody Design and Development of Innovative Bi-Specific Antibodies | ProBio CDMO 01-07-2021 / Dr. Li Chen, Senior Project Manager, ProBio Webinar about SMAB (single-domain antibody fused to monoclonal antibody). Learn More
Therapeutic Antibody One Stop Solution for CAR Lead Generation | ProBio CDMO 01-07-2021 / Alex Chen, Group Leader of Project Manager, Discovery Department, ProBio Learn More